ImmunologybioRxivPreprint
Targeting IL-2 to inflamed tissues via oxidation-specific epitopes enables third-generation bispecific IL-2 therapeutics
Thomas Vazquez, Monica Cuevas-martinez, Nicolas Billiald…·David Klatzmann
This paper develops a third-generation IL-2 therapeutic that targets inflamed tissues via oxidation-specific epitopes, showing improved therapeutic benefit in multiple inflammation models.